EMVision Medical Devices Ltd

Equities

EMV

AU0000028375

Advanced Medical Equipment & Technology

Delayed Australian S.E. 08:46:03 2024-04-18 pm EDT 5-day change 1st Jan Change
2.29 AUD -0.43% Intraday chart for EMVision Medical Devices Ltd -0.87% +35.10%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EMVision Medical Devices Secures AU$15.28 Million Investment from Keysight Technologies MT
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 CI
EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc. CI
EMVision Medical Devices Secures Nearly AU$3 Million R&D Tax Rebate for Fiscal Year 2023 MT
EMVision Medical Devices Enrolls 150 Patients for Brain Scanner Trials MT
EMVision Medical Devices Assembles 28-Antenna Prototype of Helmet Scanner; Shares Jump 12% MT
Emvision Reports Positive Interim Results from Stage II Trial of Stroke Detection Algorithm MT
EMVision Medical Devices Ltd Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Emvision Medical Begins Enrollment at Second Site for Portable Brain Scanner Stage Two Trial MT
Emvision Medical Devices Limited Receives $1.75 Million Manufacturing Grant Award CI
Emvision Medical Devices Appoints CEO MT
EMVision Medical Devices Ltd. Announces Leadership Transition, Effective July 1, 2023 CI
EMVision Medical Devices Ltd. Appoints Forough Khandan as Chief Technology Officer CI
EVision Medical Devices Begins Stage 2 Clinical Trial for Portable Brain Scanner MT
EMVision Medical Devices Limited Appoints Professor Alan Coulthard to Clinical Advisory Board CI
EMVision Medical Devices Ltd Reports Earnings Results for the Half Year Ended December 31, 2022 CI
EMVision Medical Devices Completes Enrollment for Stage 1 Clinical Trial for Brain Scanning Technology MT
EMVision Medical Devices Ltd Completes Clinical Trial Stage 1 Enrolment CI
EMVision Medical Devices Advances Clinical Trial for Portable Brain Scan Device, Secures Grant Funding Milestone MT
EMVision Medical Devices Limited Provides an Update on Its Clinical Trial and Achievement of an Important Technical Development Milestone CI
EMVision Medical Devices Secures R&D Tax Refund for FY22 MT
Emvision Medical Devices Starts First Stage of Multicenter Clinical Trial; Shares Up 3% MT
EMVision Commences Clinical Trial CI
EMVision Medical Devices Advances Development of Portable Brain Scanner with Clinical Trial Delivery; Shares Rally 16% MT
EMVision Medical Devices Ltd Announces its Portable Brain Scanner Delivered to First Clinical Site CI
Chart EMVision Medical Devices Ltd
More charts
EMVision Medical Devices Limited is an Australia-based medical device company developing an approach to looking inside the human body. The Company is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The Company is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Company's product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EMV Stock
  4. News EMVision Medical Devices Ltd
  5. EMVision Medical Devices : Validates Importance of Brain Scanner Device for Mobile Neuroimaging Applications